Atlantic Sapphire, Hofseth to form salmon byproducts joint venture

The joint venture is expected to take aim at the US market for byproducts.

Atlantic Sapphire CEO Johan E. Andreassen. Front page: Hofseth Biocare Chairman Roger Hosfeth (Photo: Morten Hjertø)
Atlantic Sapphire CEO Johan E. Andreassen. Front page: Hofseth Biocare Chairman Roger Hosfeth (Photo: Morten Hjertø)Foto: Anders Furuset
Published 1 November 2019, 18:03Updated 4 November 2019, 20:49